μ-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion

Molecular Brain Research

Volumn 121, Issue 1-2, 2004, Pages 123-130

  Hall, F Scott ^a   Goeb, Michelle ^a   Li, Xiao Fei ^a   Sora, Ichiro ^a,b   Uhl, George R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cocaine; Conditioned place preference; Dopamine; Gene knockout; Opiates; Transgenic mice

Indexed keywords

COCAINE; MU OPIATE RECEPTOR; LOCAL ANESTHETIC AGENT;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIZATION; HETEROZYGOSITY; HOMOZYGOSITY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REDUCTION; SENSITIZATION; SUBSTANCE ABUSE; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; COMPARATIVE STUDY; GENETICS; HETEROZYGOTE; HOMOZYGOTE; INSTRUMENTAL CONDITIONING; METABOLISM; MOUSE MUTANT;

MUS MUSCULUS;

ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; HETEROZYGOTE; HOMOZYGOTE; LOCOMOTION; MICE; MICE, KNOCKOUT; RECEPTORS, OPIOID, MU;

EID: 1842855964     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.10.024     Document Type: Article

References (78)

1. Becker A., Grecksch G., Brodemann R., Kraus J., Peters B., Schroeder H., Thiemann W., Loh H.H., Hollt V. Morphine self-administration in μ-opioid receptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:2000;584-589.
2. Becker A., Grecksch G., Kraus J., Loh H.H., Schroeder H., Hollt V. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;296-302.
3. Bozarth M.A., Wise R.A. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 28:1981;551-555.
4. Bozarth M.A., Wise R.A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science. 224:1984;516-517.
5. Britt M.D., Wise R.A. Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker. Brain Res. 258:1983;105-108.
6. Carroll M.E., Lac S.T. Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology. 106:1992;439-446.
7. Castane A., Valjent E., Ledent C., Parmentier M., Maldonado R., Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology. 43:2002;857-867.
8. Cazala P., Darracq C., Saint-Marc M. Self-administration of morphine into the lateral hypothalamus in the mouse. Brain Res. 416:1987;283-288.
9. Comer S.D., Lac S.T., Curtis L.K., Carroll M.E. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J. Pharmacol. Exp. Ther. 267:1993;1470-1477.
10. Comer S.D., Lac S.T., Wyvell C.L., Carroll M.E. Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. cocaine self-administration in rats maintained under FR schedules. Psychopharmacology (Berl.). 125:1996;355-360.
11. Corrigall W.A. Heroin self-administration: effects of antagonist treatment in lateral hypothalamus. Pharmacol. Biochem. Behav. 27:1987;693-700.
12. Corrigall W.A., Vaccarino F.J. Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol. Biochem. Behav. 30:1988;443-450.
13. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118:2001;61-65.
14. Cunningham C.L., Niehus D.R., Malott D.H., Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology. 107:1992;385-393.
15. David V., Cazala P. A comparative study of self-administration of morphine into the amygdala and the ventral tegmental area in mice. Behav. Brain Res. 65:1994;205-211.
16. David V., Cazala P. Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice. Psychopharmacology (Berl.). 150:2000;24-34.
17. Frost J.J., Mayberg H.S., Sadzot B., Dannals R.F., Lever J.R., Ravert H.T., Wilson A.A., Wagner H.N. Jr., Links J.M. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. J. Cereb. Blood Flow Metab. 10:1990;484-492.
18. Fuchs P.N., Roza C., Sora I., Uhl G., Raja S.N. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and μ-opioid receptor knockout mice. Brain Res. 821:1999;480-486.
19. Gabilondo A.M., Meana J.J., Garcia-Sevilla J.A. Increased density of μ-opioid receptors in the postmortem brain of suicide victims. Brain Res. 682:1995;245-250.
20. Gerrits M.A., Patkina N., Zvartau E.E., van Ree J.M. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology (Berl.). 119:1995;92-98.
21. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by μ-opioid and κ-opioid receptors. J. Neurosci. 22:2002;1146-1154.
22. Hall F.S., Sora I., Uhl G.R. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl.). 154:2001;43-49.
23. Hall F.S., Li X.F., Sora I., Xu F., Caron M., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience. 115:2002;153-161.
24. Hall F.S., Li X.-F., Goeb M., Hogatt H., Sora I., Uhl G.R. Congenic C57BL/6 m opiate receptor (MOR) knockout mice: baseline and opiate effects. Genes Brain & Behav. 2:2003;114-121.
25. F.S. Hall, I. Sora, G.R. Uhl, The molecular mechanisms underlying the behavioural effects of cocaine, Current Pharmacogenomics, in press.
26. Herz A. Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharm. 76:1998;252-258.
27. Hosohata Y., Vanderah T.W., Burkey T.H., Ossipov M.H., Kovelowski C.J., Sora I., Uhl G.R., Zhang X., Rice K.C., Roeske W.R., Hruby V.J., Yamamura H.I., Lai J., Porreca F. Delta-opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. Eur. J. Pharmacol. 388:2000;241-248.
28. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12:1998;49-53.
29. Kitanaka N., Sora I., Kinsey S., Zeng Z., Uhl G.R. No heroin or morphine 6beta-glucuronide analgesia in μ-opioid receptor knockout mice. Eur. J. Pharmacol. 355:1998;R1-R3.
30. Kitchen I., Slowe S.J., Matthes H.W.D., Kieffer B. Quantitative autoradiographic mapping of μ, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene. Brain Res. 778:1997;73-88.
31. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12:1992;2623-2632.
32. Kosten T.A., Marby D.W., Nestler E.J. Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment. Life Sci. 49:1991;L201-L206.
33. Kreek M.J. Cocaine, dopamine and the endogenous opioid system. J. Addict. Dis. 15:1996;73-96.
34. Kuzmin A.V., Gerrits M.A., van Ree J.M., Zvartau E.E. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci. 60:1997;L-257.
35. Kuzmin A.V., Gerrits M.A., Zvartau E.E., van Ree J.M. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice. Eur. Neuropsychopharmacol. 10:2000;447-454.
36. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404.
37. Liu Q.R., Sora I., Hall S., Uhl G.R. Genes regulated by μ agonist and μ deletion: microarray studies. International Narcotics Research Conference Abstract. 2000;. S216:10.
38. Lukas S.E., Mello N.K., Drieze J.M., Mendelson J.H. Buprenorphine- induced alterations of cocaine's reinforcing effects in rhesus monkey: a dose-response analysis. Drug Alcohol Depend. 40:1995;87-98.
39. Mansour A., Fox C.A., Thompson R.C., Akil H., Watson S.J. μ-opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 643:1994;245-265.
40. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene [see comments]. Nature. 383:1996;819-823.
41. Mello N.K., Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology. 14:1996;375-424.
42. Mello N.K., Negus S.S. Interactions between kappa opioid agonists and cocaine, Preclinical studies. Ann. N.Y. Acad. Sci. 909:2000;104-132.
43. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science. 245:1989;859-862.
44. Mello N.K., Mendelson J.H., Bree M.P., Lukas S.E. Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;926-939.
45. Mello N.K., Lukas S.E., Kamien J.B., Mendelson J.H., Drieze J., Cone E.J. The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 260:1992;1185-1193.
46. Mello N.K., Kamien J.B., Lukas S.E., Mendelson J.H., Drieze J.M., Sholar J.W. Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J. Pharmacol. Exp. Ther. 264:1993;530-541.
47. Mello N.K., Mendelson J.H., Lukas S.E., Gastfriend D.R., Teoh S.K., Holman B.L. Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies. Harv. Rev. Psychiatry. 1:1993;168-183.
48. Mizoguchi H., Narita M., Oji D.E., Suganuma C., Nagase H., Sora I., Uhl G.R., Cheng E.Y., Tseng L.F. The μ-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in μ-opioid receptor knockout mice. Neuroscience. 94:1999;203-207.
49. Mizoguchi H., Wu H.E., Narita M., Hall F.S., Sora I., Uhl G.R., Nagase H., Tseng L.F. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the μ-opioid receptor knockout mouse. Neuroscience. 115:2002;715-721.
50. Moriwaki A., Wang J.B., Svingos A., van Bockstaele E., Cheng P., Pickel V., Uhl G.R. mu Opiate receptor immunoreactivity in rat central nervous system. Neurochem. Res. 21:1996;1315-1331.
51. Narita M., Mizoguchi H., Sora I., Uhl G.R., Tseng L.F. Absence of G-protein activation by μ-opioid receptor agonists in the spinal cord of μ-opioid receptor knockout mice. Br. J. Pharmacol. 126:1999;451-456.
52. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237:1982;429-440.
53. Park Y., Ho I.K., Fan L.-W., Loh H.H., Ko K.H. Region specific incrase of dopamine receptor D1/D2 mRNA expression in the brain of μ-opioid receptor knockout mice. Brain Res. 894:2001;311-315.
54. Qiu C., Sora I., Ren K., Uhl G., Dubner R. Enhanced delta-opioid receptor-mediated antinociception in μ-opioid receptor-deficient mice. Eur. J. Pharmacol. 387:2000;163-169.
55. 1-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats. Neurosci. Lett. 332:2002;159-162.
56. Rice O.V., Gordon N., Gifford A.N. Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice. Brain Res. 945:2002;135-138.
57. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W., Koob G.F., Gold L.H. μ-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293:2000;1002-1008.
58. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
59. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1:1998;132-137.
60. Rodefer J.S., Mattox A.J., Thompson S.S., Carroll M.E. Effects of buprenorphine and an alternative nondrug reinforcer, alone and in combination on smoked cocaine self-administration in monkeys. Drug Alcohol Depend. 45:1997;21-29.
61. Skoubis P.D., Matthes H.W., Walwyn W.M., Kieffer B.L., Maidment N.T. Naloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice. Neuroscience. 106:2001;757-763.
62. Sora I., Funada M., Uhl G.R. The μ-opioid receptor is necessary for [D-Pen2, D-Pen5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324:1997;R1-R2.
63. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1544-1549.
64. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7699-7704.
65. Sora I., Li X.F., Funada M., Kinsey S., Uhl G.R. Visceral chemical nociception in mice lacking μ-opioid receptors: effects of morphine, SNC80 and U-50,488. Eur. J. Pharmacol. 366:1999;R3-R5.
66. Sora I., Elmer G., Funada M., Pieper J., Li X.F., Hall F.S., Uhl G.R. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology. 25:2001;41-54.
67. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., Uhl G.R. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5300-5305.
68. Svingos A., Moriwaki A., Wang J.B., Uhl G.R., Pickel V. μ-opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rats nucleus accumbens. J. Neurosci. 17:1997;2585-2594.
69. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672.
70. Uhl G.R., Hall F.S., Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry. 7:2002;21-26.
71. Vaccarino F.J., Bloom F.E., Koob G.F. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology. 86:1985;37-42.
72. Walker J.R., Ahmed S.H., Gracy K.N., Koob G.F. Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats. Brain Res. 854:2000;85-92.
73. 5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp. Neurol. 375:1996;659-674.
74. Wang H., Moriwaki A., Wang J.B., Uhl G.R., Pickel V. Ultrastructual immunocytochemical localization of μ-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putament nucleus. Neuroscience. 81:1997;757-771.
75. Wang H., Moriwaki A., Wang J.B., Uhl G.R., Pickel V.M. Ultrastructural immunocytochemical localization of μ-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus. Neuroscience. 81:1997;757-771.
76. Winger G., Skjoldager P., Woods J.H. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J. Pharmacol. Exp. Ther. 261:1992;311-317.
77. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:2000;465-471.
78. Yoo J.-H., Yang E.-M., Lee S.-Y., Loh H.H., Ho I.K., Jang C.-G. Differential effects of morphine and cocaine on locomotor activity and sensitization in μ-opioid receptor knockout mice. Neurosci. Lett. 344:2003;37-40.